Role of hysteroscopy in management of persistent mole

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201601222576N11

Enrollment

Registered

2016-08-26

Start date

2016-02-02

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Molar Pregnancy. Hydatidiform mole, unspecified

Interventions

Intervention: Hysteroscopic resection of molar tissues in 30 patients.

Treatment - Surgery

Intervention: Hysteroscopic resection of molar tissues in 30 patients

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all patients with persistent mole(residual of pregnancy in trans vaginal sonography and positive hCG after D&C) are recruited in the study. Exclusion criterion: patients who prefer chemotherapy instead of hysteroscopy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
B-hCG levels decrease. Timepoint: After one week. Method of measurement: ml/Unit/ml.	—

Secondary

Measure	Time frame
No residuea of pregnancy after hysteroscopy. Timepoint: After one week. Method of measurement: Trans vaginal sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

fatedavtanha@gmail.com+98 21 4216 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026